Chronic Fatigue Syndrome, Dysphagia, Exhaustion; Syndrome, Fatigue, Fibromyalgia, Irritable Bowel Syndrome, Somatic Symptom
Conditions
Keywords
bodily stress syndrome, functional somatic symptoms, functional somatic syndrome
Brief summary
This cohort study implements patient reported outcome measures (PROMs) for patients with bodily stress syndrome in a clinic for functional disorders.
Detailed description
The Sympa Cohort study is a prospective, single site cohort study that consists of administration of PROMs questionnaires to patients that attend the Clinic for Functional Disorders at Helsinki University hospital (HUS). The questionnaires are handed out to the study population within seven days before their first visit at the clinic, and then at the following 3, 6 and 12 months. The study population consists of consecutive adult patients that are referred to the clinic either from other hospital units or primary care. The collected data will later be linked with national registries on diagnoses, medication use and work ability. The Sympa Cohort study may have implications in targeting the factors influencing functional outcomes and quality of life reported by patients with bodily stress syndrome. It will also form a quality register for the Clinic and characterize the first systematic collection of PROMs related to these disorders in Finland.
Interventions
BEHAVIORALPsychosocial interventions
Cognitive behavioural therapy (CBT) based individual and group intervention
Sponsors
Helsinki University Central Hospital
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes
Inclusion criteria
* All genders * Age 18-80 years * Referred to Clinic for Functional Disorders either from other hospital units or from primary care * Willingness to be enrolled in the study, by signing the informed consent
Exclusion criteria
* Patients not able to fill in the forms in Finnish or due to physical constraints (e.g. dystonia) * Symptoms are likely due to a somatic disorder
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Self-rated global health improvement | 12 months | Measured by clinical improvement scale (clinical global improvement, CGI), a five-point Likert scale |
| Functional ability | 12 months | Measured by WHODAS 2.0 |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| EUROHIS-QOL-8 | 3, 6 and 12 months | Health related quality of life |
| 15D | 3, 6 and 12 months | Health related quality of life |
| PHQ-9 | 3, 6 and 12 months | Depression |
| RS-14 | 3, 6 and 12 months | Resilience |
| SSD-12 | 3, 6 and 12 months | Symptom severity |
| GAD-7 | 3, 6 and 12 months | Anxiety |
Countries
Finland
Contacts
Primary ContactHelena Liira, MD, PhD
Backup ContactJari Arokoski, MD, PhD
Outcome results
None listed